| The Kyleena™ Satisfaction Study (KYSS) provided the first real-world data on 19.5mg levonorgestrel-releasing intrauterine system (LNG-IUS-19.5mg) use in routine clinical practice in Germany. These data demonstrated the suitability of LNG-IUS-19.5mg for a broad population, including young and nulliparous women. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.